Hero

Celyad annonce la nomination de Filippo Petti en tant que Chief Financial Officer

Celyad annonce la nomination de Filippo Petti en tant que Chief Financial Officer

A propos de Celyad

Rendre l'Impossible Possible

Celyad est une société biopharmaceutique de stade clinique spécialisée dans le développement de thérapies cellulaires. Nous utilisons notre expertise en développement cellulaire pour transformer des technologies innovantes en médicaments candidats destinés à traiter diverses maladies graves pour lesquelles le besoin médical reste insatisfait, telles que le cancer.

Dernière actualité

Celyad annonce la nomination de Filippo Petti en tant que Chief Financial Officer

Celyad annonce la nomination de Filippo Petti en tant que Chief Financial Officer

Margo Roberts rejoint le Conseil d’Administration et le Comité Scientifique de Celyad

Margo Roberts rejoint le Conseil d’Administration et le Comité Scientifique de Celyad

La FDA a accepté l’IND de Celyad pour CYAD-101, un premier candidat CAR-T allogénique ne faisant pas appel à de l’édition du génome

La FDA a accepté l’IND de Celyad pour CYAD-101, un premier candidat CAR-T allogénique ne faisant pas appel à de l’édition du génome

Découvrez toute l'actualité

Carousel

Flux sociaux

Celyad Appoints Filippo Petti as Chief Financial Officer. Read the Press Release: https://t.co/wplaQWDT2q https://t.co/HTjlJhoHh2

1 week ago

Celyad Appoints Filippo Petti as Chief Financial Officer. Read the Press Release: https://t.co/wplaQWDT2q https://t.co/HTjlJhoHh2

RT @EdisonHealth: FDA signs off on @CelyadSA 's trial design with its allogeneic #CART CYAD-101 in colorectal cancer. Potential start in Q4…

1 week ago

RT @EdisonHealth: FDA signs off on @CelyadSA 's trial design with its allogeneic #CART CYAD-101 in colorectal cancer. Potential start in Q4…

RT @ChristianHomsy: Welcome to Elena Spanjaard to our team @CelyadSA. Elena will lead global RA. She headed RA for Pfizer CAR T program pri…

1 week ago

RT @ChristianHomsy: Welcome to Elena Spanjaard to our team @CelyadSA. Elena will lead global RA. She headed RA for Pfizer CAR T program pri…

Dr. Margo Roberts joins Celyad’s Board of Directors and Scientific Committee https://t.co/g0yw6yX6Kh https://t.co/YZSblHdk8D

1 week ago

Dr. Margo Roberts joins Celyad’s Board of Directors and Scientific Committee https://t.co/g0yw6yX6Kh https://t.co/YZSblHdk8D

Celyad Appoints Filippo Petti as Chief Financial Officer. Read the Press Release: https://t.co/wplaQWDT2q https://t.co/HTjlJhoHh2

1 week ago

Celyad Appoints Filippo Petti as Chief Financial Officer. Read the Press Release: https://t.co/wplaQWDT2q https://t.co/HTjlJhoHh2

RT @EdisonHealth: FDA signs off on @CelyadSA 's trial design with its allogeneic #CART CYAD-101 in colorectal cancer. Potential start in Q4…

1 week ago

RT @EdisonHealth: FDA signs off on @CelyadSA 's trial design with its allogeneic #CART CYAD-101 in colorectal cancer. Potential start in Q4…

RT @ChristianHomsy: Welcome to Elena Spanjaard to our team @CelyadSA. Elena will lead global RA. She headed RA for Pfizer CAR T program pri…

1 week ago

RT @ChristianHomsy: Welcome to Elena Spanjaard to our team @CelyadSA. Elena will lead global RA. She headed RA for Pfizer CAR T program pri…

Dr. Margo Roberts joins Celyad’s Board of Directors and Scientific Committee https://t.co/g0yw6yX6Kh https://t.co/YZSblHdk8D

1 week ago

Dr. Margo Roberts joins Celyad’s Board of Directors and Scientific Committee https://t.co/g0yw6yX6Kh https://t.co/YZSblHdk8D